Kingfisher Capital LLC Bristol Myers Squibb CO Transaction History

Kingfisher Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $1,794 - $2,006	-31 Reduced 0.83%	3,702 $215,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $9,492 - $10,540	149 Added 4.16%	3,733 $238,000
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $131 - $149	2 Added 0.06%	3,584 $248,000
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $181,677 - $215,131	-2,653 Reduced 42.55%	3,582 $258,000
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $810 - $479,097	6,235 New	6,235 $443,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kingfisher Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kingfisher Capital LLC with notifications on news.